When Should BRCA Carriers Start Breast Cancer Screening?

For individuals who carry a BRCA1 or BRCA2 gene mutation, female breast cancer screening starts much earlier and happens more frequently than it does for the general population ^[1][2]. If you choose surveillance over risk-reducing surgery (like a preventative mastectomy), the National Comprehensive Cancer Network (NCCN) guidelines recommend that breast awareness—becoming familiar with the normal look and feel of your breasts—begins at age 18 ^[3]. Professional clinical breast exams should begin at age 25 ^[3]. Annual breast MRI scans should begin between ages 25 and 29, and annual mammograms are added to your screening routine starting at age 30 ^[4].

The Recommended Screening Timeline

Because BRCA mutations significantly increase the lifetime risk of developing breast cancer, detecting changes in the breast tissue as early as possible is the primary goal ^[2]. The standard timeline recommended by experts is:

• Age 18: Begin breast awareness so you can report any changes to your doctor ^[3].
• Age 25: Begin having a clinical breast exam with your doctor every 6 to 12 months. This is a physical examination of your breast tissue by a medical professional ^[3].
• Ages 25 to 29: Begin annual breast MRI (Magnetic Resonance Imaging) scans ^[4]. Breast MRIs use magnets and radio waves to create detailed images of the breast tissue and are exceptional at finding very small abnormalities in younger, denser breasts ^[3].
• Age 30: Add an annual mammogram to your screening routine ^[4].

Note on family history: If you have a close family member who was diagnosed with breast cancer at a very young age, your doctor may recommend starting your imaging 5 to 10 years before their diagnosis age ^[3]. However, this early imaging almost exclusively relies on MRIs. Mammograms are generally avoided before age 25 to minimize radiation exposure to young, developing breast tissue ^[3][4].

Staggering Your Scans

Once you reach age 30 and are receiving both an MRI and a mammogram every year, your medical team will likely recommend staggering these scans ^[5][6].

Staggering means you schedule one type of scan every six months rather than doing both at the same time. For example, you might have your breast MRI in January and your mammogram in July.

This six-month rotation creates a “safety net.” Breast cancers associated with BRCA mutations—particularly BRCA1—can sometimes grow quickly between annual screenings ^[7]. By staggering your scans, a radiologist is looking at your breast tissue twice a year, giving you the best possible chance of catching any changes early ^[5][6]. This staggered screening routine typically continues until age 75, after which your care team will tailor recommendations based on your overall health.

BRCA1 vs. BRCA2 Considerations

While the timeline is generally the same for both mutations, how your tissue responds to different scans can vary based on which gene is mutated:

• BRCA1: Cancers associated with BRCA1 mutations are often highly visible on MRIs, and MRI has been shown to catch almost all lesions in BRCA1 carriers ^[8]. Mammograms add only a small amount of extra sensitivity for these carriers ^[9].
• BRCA2: Cancers associated with BRCA2 mutations are more likely to show up as calcifications (tiny calcium deposits) on a mammogram ^[10]. Because of this, mammograms play a vital role in detecting cancer early for BRCA2 carriers, especially for those aged 40 and younger ^[9].

Ultimately, MRI-detected lesions tend to be caught when they are significantly smaller than those detected by non-MRI methods, which is why MRIs are introduced at age 25 ^[10].

Navigating Screening During Pregnancy and Beyond

The recommended screening ages overlap with prime childbearing years. It is important to know that screening timelines often shift during pregnancy and breastfeeding. For instance, MRIs with contrast are generally avoided during pregnancy. Always inform your medical team if you are pregnant or breastfeeding so they can adjust your surveillance plan safely.

Lastly, remember that while this page focuses on female breast cancer screening, Hereditary Breast and Ovarian Cancer Syndrome also significantly increases the risk of ovarian cancer, and breast cancer in males. Comprehensive care requires discussing both breast and ovarian surveillance, as well as prophylactic surgical options, with your care team.